biostudies-literatureUnknown100(2)Rodon PNCI NIH HHSHaematologicae56-9https://www.ebi.ac.uk/biostudies/studies/S-EPMC4803137biostudies-literaturePhase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.PMC4803137P01 CA155258Royer BMoreau PLenain PLeleu XCony-Makhoul PVilque JPJardel HKolb BBanos AStoppa AMChaleteix CDejoie TRoussel MGarderet LDib MPegourie BMathiot CRodon PCasassus PHulin CBenboubker LFontan JBenramdane RTiab MFitoussi ODecaux OPetillon MOTraulle CAnglaret BAvet-Loiseau HfalsePhase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.2015-01-01T00:00:00Z2015 Feb2025-05-29T21:25:25.331Z2024-11-08T17:37:27.85ZS-EPMC48031372539883210.3324/haematol.2014.110890